Clinical Trial Update: Focused Ultrasound and Gemcitabine in Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the combination of focused ultrasound with gemcitabine for breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Patrick Dillon, MD | Conditions: Breast Cancer, Breast Neoplasms | Phase 1 | Status: RECRUITING